Abstracts Open: Prevention – Treatment – Recovery
For decades our communities have been plagued by a relatively small group of drugs that have, and indeed continue to cause addiction and its associated adverse health outcomes. Other than alcohol, these drugs have been predominately, cannabis, cocaine, heroin and methamphetamine, heroin with contributions from benzodiazepines and some other miscellaneous illicit drugs and some licit prescribed drugs such as dexamphetamine, oxycodone.
Over the last several years numerous novel psychoactive drugs (NPS) have appeared on the streets, numbering in the hundreds globally, many of which have been seen in this country. These include the strong stimulants based on the cathinone nucleus (beta-keto analogs of amphetamines), synthetic cannabinoids, designer opioids and benzodiazepines and a host of hallucinogens such as the NBOMe series.
This keynote from Dr. Olaf Drummer, Department of Forensic Medicine, Monash University, will summarise what NPS have been detected in recent times and what is known about their pharmacology, harmfulness and addiction potential.
The 4th Australian and New Zealand Addiction Conference will be held at the Mantra on View Hotel, Gold Coast on the 15th to 17th of May 2017.
Accepted abstracts will have the option of being published in either the peer or non peer reviewed book of abstracts.
APPLICATIONS TO PRESENT CLOSE TUESDAY 14 FEBRUARY 2017 – SUBMIT YOUR ABSTRACT HERE.
WHO SHOULD ATTEND?